Scott Gottlieb's Meteoric Rise?

This opinion piece presents the opinions of the author. It does not necessarily reflect the views of BioSpace.

Tom Price is out as head of HHS, thanks to playing fast-and-loose with taxpayers' dollars when it came to travel. So who will replace him? One leading candidate is FDA Commissioner Scott Gottlieb, who has won praise from both sides of the aisle since taking over the agency. Gottlieb has been around Washington a long time, with positions at  the FDA and CMS as well as various think tanks. But his recent rise to prominence has been rapid…and could continue further. He has reportedly been very effective at FDA, mixing a strong vision for reform with a technocratic management style. It would be interesting to see how that approach would translate at the much larger HHS.

Here's a roundup of these stories and other top career news from the past month.

• Double Duty: FDA Head in the Running to Lead the HHS After Flightgate Scandal
   
• Why AstraZeneca PLC CEO Took a Job His Friends Called a Suicide Mission
   
• GlaxoSmithKline's Pharma Chief Lands Job at Chinese PE Firm
   
• Flexion Eyes Creation of 100 New Sales Jobs to Sell Just-Approved Osteoarthritis Drug
   
• AstraZeneca May Move Some Manufacturing, R&D Out Of The UK Due To Brexit

Read More From Karl Thiel:
Novartis Has Set a Tricky Precedent in Gene Therapy